CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- 4 Shares withheld for taxes President & CEO gave up 4,333 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Development Officer acquired 22,667 shares (grant or award)
- 4 Grant or award President & CEO acquired 80,897 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale 10% owner sold 262,881 shares at $19.15 ($5,034,250)
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 21 of 33 · 652 filings